Active, Not Recruiting
A Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of Prosetin in Healthy Volunteers and Participants With ALS
NCT05279755
- Conditions
- Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Worldwide Clinical Trials Early Phase Services San Antonio, Texas, United States
- The Neuro - Montréal Neurological Institute-Hospital Montreal, Quebec, Canada
- University Medical Center Utrecht Utrecht, Netherlands